Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
复制标题

DOI:
10.1016/s1077-9108(08)79091-1
复制
发表时间:
2009
期刊:
Yearbook of Pathology and Laboratory Medicine
影响因子:
--
通讯作者:
F.A.M. Bordonaba
F.A.M. Bordonaba
中科院分区:
其他
文献类型:
--
作者:
F.A.M. Bordonaba

文献摘要

被引文献

相似文献